Navigation Links
UAlberta researcher pinpoints prescription for successful Primary Care Networks
Date:1/25/2013

these new, multidisciplinary mechanisms," said Reay. "These managers had a positive attitude and they set up a number of different ways that almost made them keep trying it for awhile. As they kept trying it, they made them talk about it and really think through how it was going."

Communication, space key components

Reay says that a re-organization and re-allocation of physical space was critical in developing teamwork and facilitating communication. But, the ability to communicate and to disagree also seemed to make the successful PCNs. Those who had not made successful transition were pleasant, but she said they constantly claimed to be "almost ready" to make the change, a sign that perhaps hid underlying communications issues. Those leaders that had managed the difficult conversations and found the ability to compromise and move forward were models of success.

"(Managers) encouraged people to disagree so that you could have a more full discussion about what was going on and really think through how to manage it," she said.

PCNS provide benefit for all

Reay said the doctors she spoke with are sold on PCNs because they allow them greater freedom to practice medicine the way they want, provide for maintained contact with their patients and offer them great work-life balance. As economic issues mean that healthcare has to do more with less, she says this model permits the PCNs to focus on healthcare needs of their patient community areas such as mental health, diabetes, cardiac care, etc and work preventatively providing counseling and information to people at-risk for chronic diseases.

"Patients actually like this model. They like the fact that they see their physicians still, but they don't have to rely on those quick office visits in order to ask questions and get more information and learn about whatever it may be that they have, said Reay. "In a business world, we'd say that this model is
'/>"/>

Contact: Jamie Hanlon
jamie.hanlon@shaw.ca
780-619-3136
University of Alberta
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. New UAlberta research shows commonly prescribed medications could have adverse effects
2. Alternative medicine use high among children with chronic conditions: UAlberta medical research
3. Alternative medicine use high amoung children with chronic conditions: UAlberta medical research
4. UAlberta medical researchers discover new potential chemotherapy
5. UAlberta medical researchers make key discovery in fight against Alzheimers disease
6. UAlberta prostate cancer researcher and team developing homing beacon drugs to target cancer cells
7. Tumor cells engineer acidity to drive cell invasion, Moffitt Cancer Center researchers say
8. Researchers say its time to treat anemia seriously
9. Rush researchers studying stem cell therapy to repair damaged knee cartilage
10. Researchers discover new mutations driving malignant melanoma
11. CDC Researchers Spot Increase in New Stomach Bug Strain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Deaf teens have stronger language and reading skills if their ... study suggests. Researchers looked at a group of deaf ... through an infant screening program conducted in the 1990s. ... those who were screened by the time they were 9 ... children who weren,t screened as infants. This new study ...
(Date:11/26/2014)... Nov. 26, 2014 (HealthDay News) -- New regulations to ... plants and factories were issued Wednesday by the U.S. ... asthma, heart disease and premature death. The new ... from 75 parts per billion to between 65 to ... ozone pollution standards in line with the latest science ...
(Date:11/26/2014)... 2014 The report “Laboratory Information ... (On-premise, Hosted, SaaS), End User Labs (Clinical, Molecular ... (Software, Services) - Global Forecast to 2019” provides ... challenges, opportunities, current market trends, and strategies impacting ... forecasts of the revenue and market growth. , ...
(Date:11/26/2014)... Increasing demand for diagnostic imaging ... surgeries has paved way for consequent increase in ... various types of cancers and cardiac diseases globally ... for these owing to their use in diagnosing ... market can also be attributed to advancements in ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Gone are the ... cheap deals on Black Friday, which signifies the beginning of ... items into their shopping carts in the comfort of their ... , This Friday is going to be an occasion ... day, with an estimated $2.48 billion in revenue for online ...
Breaking Medicine News(10 mins):Health News:Spotting Hearing Problems in Infancy May Boost Reading Skills in Deaf Teens 2Health News:EPA Issues Tougher Rules on Ozone Emissions 2Health News:EPA Issues Tougher Rules on Ozone Emissions 3Health News:Laboratory Information Systems Market by Type, Delivery Mode & End Users is Estimated to Reach $1,806.1 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Laboratory Information Systems Market by Type, Delivery Mode & End Users is Estimated to Reach $1,806.1 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Laboratory Information Systems Market by Type, Delivery Mode & End Users is Estimated to Reach $1,806.1 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Contrast Media Injectors Market To 2020 - Global Industry, Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 2Health News:Contrast Media Injectors Market To 2020 - Global Industry, Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 3Health News:2014 Best Friday Deals Revealed by Top10InAction 2
... breakthrough, which could eventually lead to a practical and cost ... the US National Cancer Institute have genetically modified bacteria living ... infection. // ,Most HIV transmission occurs on the ... coated with a layer of bacteria. ,The researchers ...
... Minister Anbumani Ramadoss on Saturday urged the State Government ... 80-year-old Communicable Diseases Hospital (CDH) in Tondiarpet in north ... wards in the hospital, Anbumani told journalists that though ... controlling the cholera outbreak in the city post-rains, the ...
... a 17-year-old teenager named Daniel Hindle of Carvale Drive, Richmond, ... the verdict of 'death by misadventure.' // ,Daniel died ... lip pierced in a salon in the city. He was ... fever. Commenting on the verdict, South Yorkshire coroner ...
... LINK Applied Genomics Programme has proved to be a ... diagnose meningitis, MRSA and Chlamydia; has regenerated spinal nerve ... and has provided effective vaccines against Salmonella. This programme ... collaboration with 23 industrial partners to identify new methods ...
... global problem, the entire world is struggling against the ... as opposed to traditional foods.,Eating patterns are undergoing a ... about this fast food generation growing up. ... to launch a poster campaign to shock children away ...
... bird flu may reduce world energy demand should it evolve ... by more than 1-million barrels a day//. ,World oil ... issued by the US Energy Information Administration. “Should the ... would be profound, potentially reducing energy demand by well over ...
Cached Medicine News:Health News:Genetically modified bacteria to combat HIV 2Health News:Diligence Of Chennai Doctors Appreciated: Anbumani 2Health News:LINK Applied Genomics Programme Promises To Revolutionize Healthcare Systems 2Health News:Bird Flu Likely To Reduce World Energy Demand 2
(Date:11/26/2014)... 25, 2014  goBalto, Inc., the leading provider of ... a winner of Red Herring,s Top 100 Global ... North America award in 2013, marking its emergence as ... Red Herring,s Top 100 Global list has become ... and entrepreneurs. Red Herring editors were among the first ...
(Date:11/26/2014)... , Nov. 25, 2014   Heska Corporation ... or the "Company"), a provider of advanced veterinary diagnostic ... Robert Grieve , Executive Chair, will attend The Benchmark Company, ... The one-on-one conference will be held at The Palmer House ... from 8 a.m. to 2:30 p.m. Please email ...
(Date:11/26/2014)... LONDON , Nov. 25, 2014 Amgen ... AZN ) today announced that AMAGINE-2 TM , a pivotal, ... more than 1,800 patients with moderate-to-severe plaque psoriasis, met its ... and placebo at week 12. Brodalumab 210 mg given every ... shown to be superior to Stelara on the primary endpoint ...
Breaking Medicine Technology:goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3Heska to Attend Benchmark Micro Cap Discovery Conference 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10
... 12, 2011 Novartis Pharmaceuticals Corporation ("Novartis") announced ... (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended approval ... patients with advanced neuroendocrine tumors (NET) of pancreatic ... presentation of data from the everolimus RADIANT (RAD001 ...
... market leading EchoStim® Echogenic Insulated needle has been ... Nerve Blocks (PNBs) using nerve stimulation and ultrasound ... needle has more, brighter, easier to see reflectors, ... practitioners the benefits of using both nerve block ...
Cached Medicine Technology:Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 2Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 3Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 4Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 5Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 6Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 7Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 8Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 9Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 10
... Brachial Index (ABI) is one of the most simple to perform and useful vascular tests for assessing ... to perform a complete ABI. ... ... ...
... Auto Refractor/Keratometer. Advanced engineering, rapid ... illumination mode make it the most ... 5.5 inch High Quality Monitor ... Rapid, instantaneous readings are taken as ...
A fully automated, benchtop instrument designed for high-volume urine testing, using Siemens' proven technology in dry-pad urine chemistry analysis....
A fully automated, benchtop instrument designed for high-volume urine testing, using Siemens' proven technology in dry-pad urine chemistry analysis....
Medicine Products: